• AXIS Clinicals successfully completes 20th US FDA audit (April 2017)
  • AXIS Clinicals successfully completes MCC South Africa audit (March 2017)
  • AXIS Clinicals successfully completes GCC audit (February 2016)
  • AXIS Clinicals successfully completes 7th ANVISA – Brazil audit (March 2015)
  • AXIS Clinicals successfully completes WHO audit (March 2015)
  • AXIS Clinicals successfully completes 3rd MHRA audit (Sep 2014)
  • BA-BE studies conducted at AXIS Clinicals are accepted by Chile – ISP

Our Leadership


Dr. A. Jayachandra Reddy
Executive Director
Dr. Jaya Chandra Reddy, has more than 13 years of experience. He has completed Post Graduation in Medicine and also received FRCS from University of Edinburgh. He is responsible for setting up BA|BE centers in various countries, meeting international regulatory requirements (USFDA, UK-MHRA, WHO, ANVISA-Brazil, Turkey-MOH, DCGI and other regulatory agencies like TPP-Canada, TGA-Australia, etc.) and handling all regulatory and client audits successfully

B. Phani Bhushana Reddy
Executive Director
Mr. Phani brings more than 16 years experience in the conduct of Bio-analysis for pharmaceutical and Bio-pharmaceutics drugs. He has extensive expertise in Hormonal drugs method development & validations and metabolic profiling. Phani has published various papers on Bio-analysis in chromatography journals.


Dr. Subhra Lahiri
AVP – Clinical Research
Dr. Subhra has over 22 years of extensive experience in Clinical Research, Clinical Data Management, Pharmaceuticals and Biologics. Before joining AXIS Clinicals, he worked in various domains like Clinical Research, Clinical Data Management, Regulatory Affairs and Drug Development activities for Bharat Biotech, Biological E., Asian Clinical Trials and Avesthagen. He has experience in conducting several clinical studies including early exploratory trials, Patient population Bioequivalence studies and clinical trials in various therapeutic areas. He has obtained his PhD degree in Human Physiology from University of Calcutta.

Sidharth Mishra
Vice President, Business Development and Project Management
Mr. Sidharth brings rich experience of over 12 years in APIs, Formulations and Clinical Trials having worked in reputed pharmaceutical firms. Prior to joining AXIS, he worked as General Manager, international business for Fuji Chemical Company in Tokyo, Japan & was Head of Japan Operation for Shasun Pharmaceutical Company Ltd. Mr. Mishra has a B. Tech (Chemical Engineering) and an MBA degree


Abhijit Chaudhari
Director – Business Dev. (India / ROW)
Mr. Abhijit brings more than 14 years of experience in Pharmaceutical and Clinical Research fraternity in various domains like Business Development, Brand Management, Product Management and Project Management. Prior to AXIS Clinicals, Abhijit worked with Cadila Pharmaceuticals, GVK BIO, Actimus Biosciences; where he demonstrated success in setting and executing business strategy, leading complex cross-functional projects and developing strong customer relationships. He hold Bachelor’s degree in Pharmacy (B. Pharmacy) and Masters in Business Administration (MBA) from University of Pune.

Fact sheet

  • 2,400+ clinical studies completed since inception
  • 350+ bioanalytical methods developed
  • 50+ successful Regulatory audits
  • Global footprint of operations with sites in India, U.S & Mexico.
  • Two clinical facilities (Hyderabad & Ahmedabad) in India
  • 100+ National and International Pharma/Biotech Sponsor companies working with AXIS
  • US FDA : 500+ approvals, EMEA : 100+ approvals, Canada : 50+ approvals, Australia : 50+ approvals
  • 500+ experianced employees working globally
  • Huge database of patient population in various therapeutic areas viz. Cardiology, Opthalmology, Schizophrenia, Diabetology, Oncology. Orthopedics etc..

Copyright Axis Clinicals - All Rights Reserved